Reinstituting the Bolus - New Reasoning for an Existing Technique

Area of Science:

• Pain Management
• Neurology
• Pharmacology

Background:

• Intrathecal (IT) pump technology advancements enable precise opioid bolus dosing.
• Current pain therapy often relies on continuous infusions, which may lead to tolerance and opioid-induced hyperalgesia.
• Bolus-only dosing represents a novel approach to IT opioid administration.

Purpose of the Study:

• To investigate the safety and efficacy of morphine bolus-only intrathecal (IT) dosing.
• To compare bolus-only IT dosing with continuous delivery methods for pain management.
• To evaluate patient satisfaction, functional outcomes, and opioid dose requirements.

Main Methods:

• Utilizing improved intrathecal (IT) pump technology for accurate opioid bolus delivery.
• Administering minimal opioid doses (e.g., <1 mg IT morphine) in a bolus-only regimen.
• Comparing adverse effect rates, safety profiles, therapy satisfaction, functional scores, and dose escalation between bolus-only and continuous infusion methods.

Main Results:

• Hypothesized comparable adverse effect rates and potentially increased safety with bolus-only IT morphine dosing.
• Predicted improved therapy satisfaction and functional scores for patients on bolus-only regimens.
• Anticipated lower 24-hour opioid doses and reduced dose escalation compared to continuous delivery.

Conclusions:

• Morphine bolus-only IT dosing may offer a safer and more effective alternative to continuous infusions.
• This method has the potential to mitigate opioid tolerance and opioid-induced hyperalgesia.
• IT pumps could be considered earlier in treatment algorithms for improved pain management outcomes.